George A. Eldridge, SEE REMARKS at Aerovate Therapeutics, Inc. (AVTE), sold 1,037 shares at $19.01 ($20K) on 2022-11-22, disclosed to the SEC on 2022-11-22.
Scheduled sale ($20k) by SEE REMARKS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.45 | 780 | $15K | 75.3% |
| 2 | $20.13 | 81 | $2K | 8.1% |
| 3 | $19.00 | 2 | $38 | 0.2% |
| 4 | $19.01 | 174 | $3K | 16.4% |
| Total | $19.43 avg | 1,037 | $20K | 100% |
| Filing → |
| AVTE | SELL | 2024-04-03 | $780K | — | Filing → |
| AVTE | SELL | 2024-03-14 | $204K | — | Filing → |
| AVTE | SELL | 2024-03-11 | $736K | — | Filing → |